ID: h-85b51a8f58
Hypothesis
Microglial TREM2 state determines whether C1q-tagged substrates are cleared adaptively or converted into chronic complement-associated synaptotoxic inflammation
This hypothesis reconciles conflicting C1q phenotypes by placing receiver-cell state downstream of a common upstream C1q-tagging event.
EvidencePending (0%)📖 7 cit🗣 1 debates✓ 7 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
This hypothesis reconciles conflicting C1q phenotypes by placing receiver-cell state downstream of a common upstream C1q-tagging event. In a competent TREM2 program, microglia clear tagged material efficiently; in TREM2-impaired states, the same substrates persist, amplifying complement and bystander synapse loss.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["C1Q Deficiency<br/>Impaired Clearance of Apoptotic Cells"]
B["C1QC Assembly<br/>Heterocomplex Formation"]
C["Synaptic Pruning Dysregulation<br/>Unpruned Connections"]
D["Microglial Overactivation<br/>Complement Deposition"]
E["C3b/C4b Deposition<br/>Neuronal Surface"]
F["Synaptic Loss<br/>Excessive Pruning in AD"]
G["Long-Term Potentiation<br/>Memory Formation Impaired"]
H["Cognitive Decline<br/>AD-Related Dementia"]
A --> B
B --> C
B --> D
C --> F
D --> E
E --> F
F --> G
G --> H
style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix7 supports2 contradicts
Supports
TREM2 directly interacts with C1q in neurodegeneration-relevant contexts and appears to restrain complement-mediated synapse loss.
Supports
Microglial state is a major determinant of neurodegenerative response programs, making it plausible that identical opsonized substrates can lead to different outcomes.
Supports
TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways.
Supports
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.
Supports
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model.
Contradicts
TREM2 biology is pleiotropic, and observed effects may reflect broader changes in metabolism, clustering, or plaque handling rather than a specific C1q decision node.
Contradicts
The claim that TREM2 state alone determines adaptive versus toxic handling likely overstates causality because astrocytes, other receptors, and complement regulators also shape outcome.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — TREM2
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for TREM2,TYROBP,C1QA,C1QB,C1QC,C3 from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TREM2,TYROBP,C1QA,C1QB,C1QC,C3.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 1.0%
Volatility
Low
0.0041
Events (7d)
3
Price History
▼13.8%💾 Resource Usage
LLM Tokens
19,754
$0.0593
Total Cost
$0.0593
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF TREM2 signaling is activated pharmacologically (using agonistic antibody clone 5F12 at 10 mg/kg, i.p., 3x/week for 4 weeks) in 12-month-old TREM2-WT mice with established C1q-bound synaptic debris, | ≥40% increase in microglial engulfment of C1q-tagged synaptic elements, quantified as Iba1+ cells containing ≥3 C1q+Synapsin+ puncta | — no observation — | pending | 0.65 |
| IF TREM2 is genetically ablated (TREM2-KO) in 5xFAD amyloid model mice, THEN cortical synaptosomal C3 protein levels will increase by ≥2.5-fold at 6 months of age compared to TREM2-WT 5xFAD controls, | ≥2.5-fold increase in C3 concentration (ng/mg synaptosomal protein) and ≥1.8-fold increase in C1q subunits in TREM2-KO vs. TREM2-WT 5xFAD mice | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF TREM2 signaling is activated pharmacologically (using agonistic antibody clone 5F12 at 10 mg/kg, i.p., 3x/week for 4 weeks) in 12-month-old TREM2-WT mice with established C1q-bound synaptic debris, THEN microglial phagocytosis of C1q+ synaptic material will increase by ≥40% (measured by Iba1+C1q+
Predicted outcome: ≥40% increase in microglial engulfment of C1q-tagged synaptic elements, quantified as Iba1+ cells containing ≥3 C1q+Synapsin+ puncta
Falsification: No statistically significant increase in C1q+ synaptic debris clearance (p>0.05, Mann-Whitney U test) in TREM2-agonist treated vs. control groups; clearance remains <20% above baseline
pendingconf 55%
IF TREM2 is genetically ablated (TREM2-KO) in 5xFAD amyloid model mice, THEN cortical synaptosomal C3 protein levels will increase by ≥2.5-fold at 6 months of age compared to TREM2-WT 5xFAD controls, with corresponding increases in C1QA, C1QB, and C1QC subunits.
Predicted outcome: ≥2.5-fold increase in C3 concentration (ng/mg synaptosomal protein) and ≥1.8-fold increase in C1q subunits in TREM2-KO vs. TREM2-WT 5xFAD mice
Falsification: No significant elevation (fold-change <1.3) of C3 or C1q proteins in TREM2-KO synaptosomes; complement levels remain equivalent to or below TREM2-WT levels
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.